Publications & Posters Sigla storax (Liquidambar orientalis) mitigates in vitro methane production without disturbances in rumen microbiota and nutrient fermentation in comparison to monensinCatia PacificoAugust 4, 2023
Publications & Posters Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer TypesCatia PacificoJune 21, 2023
Publications & Posters AMICI 2023: The impact of age progression in the intestinal microbiome: insights from a European cohortCatia PacificoJune 19, 2023
Publications & Posters CIMT 2023: Application of the microbiome-based prediction test BiomeOne quantifies antibiotic, geographical and health-related effects on response to cancer immunotherapy in a large European cohortCatia PacificoMay 5, 2023
Publications & Posters Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening programCatia PacificoFebruary 17, 2023
Publications & Posters Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitisCatia PacificoNovember 22, 2022
Publications & Posters DGHO 2022: BiomeOne®: multi-centric validation of a novel microbiome-based test to predict response to cancer immunotherapyCatia PacificoOctober 11, 2022
Publications & Posters UEG 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening toolCatia PacificoOctober 11, 2022
Publications & Posters Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)Catia PacificoOctober 1, 2022
Publications & Posters ÖGP 2022: Prediction of immune checkpoint inhibitor response in non-small cell lung cancer patients using a microbiome-based biomarkerCatia PacificoOctober 1, 2022
